Skip to Content

Ranibizumab

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

S01LA04

CAS registry number (Chemical Abstracts Service)

0347396-82-1

Chemical Formula

C2158-H3282-N562-O681-S12

Molecular Weight

48349

Therapeutic Categories

Ophthalmic agent

Monoclonal antibody

Treatment of neovascular (wet) age-related macular degeneration

Angiogenesis inhibitor

Treatment of diabetic retinopathy

Vascular endothelial growth factor (VEGF) antagonist

Chemical Name

immunoglobulin G1, anti-(human vascular endotelial growt factor) Fab fragment (human - mouse monoclonal rhuFAB V2 gamma1-chain), disulfide wit human-mouse monoclonal rhuFAB V2 light chain (USAN)

Foreign Names

  • Ranibizumabum (Latin)
  • Ranibizumab (German)
  • Ranibizumab (French)
  • Ranibizumab (Spanish)

Generic Names

Brand Names

  • Lucentis
    Genentech, United States; Grupo Novartis, Spain; Haemato Pharm, Austria; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Bahrain; Novartis, Chile; Novartis, Colombia; Novartis, Czech Republic; Novartis, Ecuador; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, South Korea; Novartis, Lebanon; Novartis, Lithuania; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Serbia; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis AH, South Africa; Novartis Europharm, Austria; Novartis Europharm, Denmark; Novartis Europharm, Slovenia; Novartis Farma, Italy; Novartis Healthcare, Philippines; Novartis Ophthalmics, Singapore; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharma, Russian Federation; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide